Press Releases

Current Articles | Categories | Search | Syndication

17 September 2014  Joanne Hunter
Miniature in-line blood gas analyser launched by Sphere Medical at AAGBI 2014
By Joanne Hunter @ 08:53 :: 12 Views

Cambridge, UK – 16 September 2014 Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September. The new Proxima miniaturised blood gas analyser uniquely delivers rapid and frequent results at a patient’s bedside to enable fast response, proactive critical care.

Read More

16 September 2014  Joanne Hunter
Science and Technology Award for TMT at HUPO World Congress
By Joanne Hunter @ 09:45 :: 37 Views

15th September 2014. Proteome Sciences is delighted that HUPO (Human Proteome
Organisation) has announced that the Science and Technology Award for the
commercialisation of isobaric mass tagging technologies, including our TMT® isobaric mass
tags for labelling samples in mass spectrometers, is to be presented at the forthcoming HUPO
World Congress in Madrid. Dr Andrew Thompson, Head of Chemical Proteomics at
Proteome Sciences is amongst the team being honoured. Dr Thompson was an original
inventor of TMT® proteomics and he has also worked on the application of isobaric tags in
genomics and MALDI imaging. TMT® chemical tags, distributed through Thermo Scientific,
have become the global market leader and that position will be extended through a continuing
program of new product introductions.

Read More

11 September 2014  Joanne Hunter
The Juncker Commission: A strong and experienced team standing for change
By Joanne Hunter @ 10:19 :: 80 Views

Today, President-elect Juncker unveiled his team and the new shape of the next European Commission. After the European Union has come through one of the most testing periods in its history, one of the biggest challenges will be to convince citizens that things will change. To deliver change, the Commission needs to be open to reform. The new European Commission will be streamlined to focus on tackling the big political challenges Europe is facing: getting people back to work in decent jobs, triggering more investment, making sure banks lend to the real economy again, creating a connected digital market, a credible foreign policy and ensuring Europe stands on its own feet when it comes to energy security. The new way the Commission will be set up reflects these Political Guidelines, on the basis of which Jean-Claude Juncker was elected by the European Parliament.

Read More

04 September 2014  Joanne Hunter
Key opinion leaders provide an insight into best practice in acute cardiac care
By Joanne Hunter @ 12:06 :: 104 Views


Radiometer, a leading provider of technologically advanced acute care testing solutions, is
pleased to announce the publication of Excellence in acute cardiac care, a supplement to the
European Heart Journal: Acute Cardiovascular Care.

Read More

01 September 2014  Rebecca Bellars
Less than 40% of people in the UK understand the pathologist’s vital role in diagnosing cancer
By Rebecca Bellars @ 14:13 :: 153 Views

n the eve of the European Congress of Pathology in London, new research shows the pathologist’s critical role in tackling cancer is not widely understood.

Chalfont St Giles, 29 August 2014 – As the European Congress of Pathology begins this weekend in London, new research from GE Healthcare shows that many people do not understand the importance of the pathologist in the diagnosis and treatment of breast cancer1, the most common cancer in Europe, with more than 464,000 new cases diagnosed in 2012.

Read More

19 August 2014  Joanne Hunter
Advanced Cell Diagnostics and Leica Biosystems Begin Co-marketing Fully Automated RNA in situ Hybridization Assay
By Joanne Hunter @ 08:43 :: 160 Views

MELBOURNE, AUSTRALIA & HAYWARD, CALIFORNIA, August 13, 2014: Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced the co-marketing of ACD's RNAscope® LS ISH assays with Leica Biosystems' BOND RX research staining platform*. This agreement provides researchers with an integrated and fully automated ISH solution. The market-leading RNAscope LS reagent kits and ISH probes are available from ACD while the BOND RX instrument and associated reagents are supplied by Leica Biosystems.

Read More

12 August 2014  Joanne Hunter
Liver disease: developments in the understanding and assessment of liver fibrosis
By Joanne Hunter @ 15:27 :: 173 Views

According to recent statistics1 deaths from liver disease have risen by 40% between 2001 and 2012 and the disease is the only major disease group in which annual deaths are on the rise. With this in mind it becomes increasingly important to measure liver fibrosis, the scarring process that represents the liver’s response to injury or disease. Liver fibrosis is the final common pathway of all chronic liver disease (CLD), and most of these liver diseases are asymptomatic and the patient is unaware of the symptoms until it is often too late. 

Read More

29 July 2014  Joanne Hunter
Siemens offers educational resources to share best practice and enhance knowledge
By Joanne Hunter @ 14:35 :: 286 Views

In support of the increasing need for training and reference materials in diagnostic laboratories, Siemens Healthcare Diagnostics has announced the extended availability of a number of educational resources for laboratory staff. These  include a range of wall posters and case studies to assist haematology departments with staff development, along with a series of webinars offering personalised education, training and management solutions.

Read More

22 July 2014  Joanne Hunter
New data using EKF PointMan™ technology suggest the possibility of a simple blood test for cancers
By Joanne Hunter @ 11:17 :: 375 Views

Cardiff, UK – 21st July 2014 – EKF Diagnostics, the global diagnostics company, announces that the latest results from its collaboration with the Institute of Life Sciences at the University of Swansea, UK, have continued to confirm the effectiveness of its PointMan™ DNA enrichment technology for isolating and characterizing low-level DNA mutations in blood. This is significant since with such sensitivity, it paves the way for the possibility of using a simple blood test to screen and diagnose different cancers, as well as monitor the efficacy of anti-cancer therapies.

Read More

16 July 2014  Joanne Hunter
New Iam CMV provides rapid molecular confirmation of congenital CMV infection
By Joanne Hunter @ 10:40 :: 363 Views

DiaSorin strengthens its infectious disease diagnostic portfolio for mothers and babies with the launch of the Iam CMV assay for the molecular detection of cytomegalovirus.

DiaSorin has further expanded its range of infectious disease assays for use on the DiaSorin Liaison® Iam analyser with the launch of a new molecular assay for the rapid and reliable detection of cytomegalovirus (CMV). Intra-uterine transmission of CMV to the foetus during pregnancy is the leading viral cause of congenital infection, affecting around 1% of live births1. The DiaSorin Iam CMV assay detects clinically relevant subtypes of CMV in human amniotic fluid, plasma, urine and cerebrospinal fluid (CSF)2, making it a valuable tool for the diagnosis of maternal and foetal CMV infection in early pregnancy and for monitoring CMV infection in affected babies.

Read More

Previous Page | Next Page